Advocacy at a Glance STEVEN GROSSMAN 12/18/20 Advocacy at a Glance STEVEN GROSSMAN 12/18/20 What Will Actually Get Funded at FDA in FY 21? Read More Advocacy at a Glance STEVEN GROSSMAN 12/18/20 Advocacy at a Glance STEVEN GROSSMAN 12/18/20 House-Senate Near Completion of Combo Appropriations/COVID-19 Relief Bill Read More Analysis and Commentary STEVEN GROSSMAN 12/10/20 Analysis and Commentary STEVEN GROSSMAN 12/10/20 COVID-19 Vaccine Update: A Briefing from the FDA Read More Advocacy at a Glance STEVEN GROSSMAN 12/11/20 Advocacy at a Glance STEVEN GROSSMAN 12/11/20 FDA Commissioner and CBER Director Provide Insights on Vaccines at Alliance Briefing Read More Analysis and Commentary STEVEN GROSSMAN 12/5/20 Analysis and Commentary STEVEN GROSSMAN 12/5/20 CDRH Update and Future Priorities Read More Advocacy at a Glance STEVEN GROSSMAN 12/5/20 Advocacy at a Glance STEVEN GROSSMAN 12/5/20 CDRH Director Presents at Alliance Webinar Read More Analysis and Commentary STEVEN GROSSMAN 11/19/20 Analysis and Commentary STEVEN GROSSMAN 11/19/20 Time to Give Thanks -- Once Again Read More Advocacy at a Glance STEVEN GROSSMAN 11/20/20 Advocacy at a Glance STEVEN GROSSMAN 11/20/20 What Happened in 2020? Insights from DC's Top Election Handicapper Read More Analysis and Commentary STEVEN GROSSMAN 11/12/20 Analysis and Commentary STEVEN GROSSMAN 11/12/20 Where $40 Million Might Go for FY 21 Read More Advocacy at a Glance STEVEN GROSSMAN 11/13/20 Advocacy at a Glance STEVEN GROSSMAN 11/13/20 Progress on Appropriations; How Much Progress is Unclear Read More Analysis and Commentary STEVEN GROSSMAN 11/8/20 Analysis and Commentary STEVEN GROSSMAN 11/8/20 What Happens in the Next Few Months? Read More Advocacy at a Glance STEVEN GROSSMAN 11/8/20 Advocacy at a Glance STEVEN GROSSMAN 11/8/20 Alliance Webinar with CDRH Director Dr. Jeffrey Shuren Announced Read More Analysis and Commentary STEVEN GROSSMAN 10/31/20 Analysis and Commentary STEVEN GROSSMAN 10/31/20 Whether There Is or Whether There Isn't Read More Advocacy at a Glance STEVEN GROSSMAN 10/31/20 Advocacy at a Glance STEVEN GROSSMAN 10/31/20 Pandemic-Related Aid and Delayed Appropriations: to Be Resolved Together in Lame Duck? Read More Analysis and Commentary STEVEN GROSSMAN 10/24/20 Analysis and Commentary STEVEN GROSSMAN 10/24/20 FY 21, FY 22 Appropriations and CDER Priorities Read More Advocacy at a Glance STEVEN GROSSMAN 10/24/20 Advocacy at a Glance STEVEN GROSSMAN 10/24/20 Washington Is Waiting for the Election Read More Analysis and Commentary STEVEN GROSSMAN 10/16/20 Analysis and Commentary STEVEN GROSSMAN 10/16/20 Future Changes in Congressional Committees and the FDA Read More Advocacy at a Glance STEVEN GROSSMAN 10/16/20 Advocacy at a Glance STEVEN GROSSMAN 10/16/20 Congressional Committees Overseeing FDA Will Have Some Changes in the New Congress Read More Analysis and Commentary STEVEN GROSSMAN 10/9/20 Analysis and Commentary STEVEN GROSSMAN 10/9/20 Webinar on Budget, Workload, and Other Priorities for CDER Read More Advocacy at a Glance STEVEN GROSSMAN 10/9/20 Advocacy at a Glance STEVEN GROSSMAN 10/9/20 Life Under the Continuing Resolution Read More Newer Posts Older Posts
Advocacy at a Glance STEVEN GROSSMAN 12/18/20 Advocacy at a Glance STEVEN GROSSMAN 12/18/20 What Will Actually Get Funded at FDA in FY 21? Read More
Advocacy at a Glance STEVEN GROSSMAN 12/18/20 Advocacy at a Glance STEVEN GROSSMAN 12/18/20 House-Senate Near Completion of Combo Appropriations/COVID-19 Relief Bill Read More
Analysis and Commentary STEVEN GROSSMAN 12/10/20 Analysis and Commentary STEVEN GROSSMAN 12/10/20 COVID-19 Vaccine Update: A Briefing from the FDA Read More
Advocacy at a Glance STEVEN GROSSMAN 12/11/20 Advocacy at a Glance STEVEN GROSSMAN 12/11/20 FDA Commissioner and CBER Director Provide Insights on Vaccines at Alliance Briefing Read More
Analysis and Commentary STEVEN GROSSMAN 12/5/20 Analysis and Commentary STEVEN GROSSMAN 12/5/20 CDRH Update and Future Priorities Read More
Advocacy at a Glance STEVEN GROSSMAN 12/5/20 Advocacy at a Glance STEVEN GROSSMAN 12/5/20 CDRH Director Presents at Alliance Webinar Read More
Analysis and Commentary STEVEN GROSSMAN 11/19/20 Analysis and Commentary STEVEN GROSSMAN 11/19/20 Time to Give Thanks -- Once Again Read More
Advocacy at a Glance STEVEN GROSSMAN 11/20/20 Advocacy at a Glance STEVEN GROSSMAN 11/20/20 What Happened in 2020? Insights from DC's Top Election Handicapper Read More
Analysis and Commentary STEVEN GROSSMAN 11/12/20 Analysis and Commentary STEVEN GROSSMAN 11/12/20 Where $40 Million Might Go for FY 21 Read More
Advocacy at a Glance STEVEN GROSSMAN 11/13/20 Advocacy at a Glance STEVEN GROSSMAN 11/13/20 Progress on Appropriations; How Much Progress is Unclear Read More
Analysis and Commentary STEVEN GROSSMAN 11/8/20 Analysis and Commentary STEVEN GROSSMAN 11/8/20 What Happens in the Next Few Months? Read More
Advocacy at a Glance STEVEN GROSSMAN 11/8/20 Advocacy at a Glance STEVEN GROSSMAN 11/8/20 Alliance Webinar with CDRH Director Dr. Jeffrey Shuren Announced Read More
Analysis and Commentary STEVEN GROSSMAN 10/31/20 Analysis and Commentary STEVEN GROSSMAN 10/31/20 Whether There Is or Whether There Isn't Read More
Advocacy at a Glance STEVEN GROSSMAN 10/31/20 Advocacy at a Glance STEVEN GROSSMAN 10/31/20 Pandemic-Related Aid and Delayed Appropriations: to Be Resolved Together in Lame Duck? Read More
Analysis and Commentary STEVEN GROSSMAN 10/24/20 Analysis and Commentary STEVEN GROSSMAN 10/24/20 FY 21, FY 22 Appropriations and CDER Priorities Read More
Advocacy at a Glance STEVEN GROSSMAN 10/24/20 Advocacy at a Glance STEVEN GROSSMAN 10/24/20 Washington Is Waiting for the Election Read More
Analysis and Commentary STEVEN GROSSMAN 10/16/20 Analysis and Commentary STEVEN GROSSMAN 10/16/20 Future Changes in Congressional Committees and the FDA Read More
Advocacy at a Glance STEVEN GROSSMAN 10/16/20 Advocacy at a Glance STEVEN GROSSMAN 10/16/20 Congressional Committees Overseeing FDA Will Have Some Changes in the New Congress Read More
Analysis and Commentary STEVEN GROSSMAN 10/9/20 Analysis and Commentary STEVEN GROSSMAN 10/9/20 Webinar on Budget, Workload, and Other Priorities for CDER Read More
Advocacy at a Glance STEVEN GROSSMAN 10/9/20 Advocacy at a Glance STEVEN GROSSMAN 10/9/20 Life Under the Continuing Resolution Read More
